Bristol Myers Squibb's repotrectinib receives positive EU opinion for ROS1-positive NSCLC and NTRK-positive solid tumours

Aileron Therapeutics reveals positive topline data from Cohort 2 of Phase 1b clinical trial in idiopathic pulmonary fibrosis

Azome Therapeutics signs research and development agreement with National Center for Advancing Translational Sciences

IDEAYA announces IDE034 as development candidate; Secures global license from Biocytogen

ANGLE plc highlights dual CTC and ctDNA analysis in NSCLC research

Mabwell announces promising pre-clinical Data of 7MW4811 at the 15th World ADC Conference

Dizal submits NDA to US FDA for sunvozertinib in treating NSCLC with EGFR exon 20 mutations

Harbour BioMed submits IND application for HBM9378/SKB378 in COPD treatment

Organon adds VTAMA cream to dermatology portfolio with acquisition of Dermavant

Merck and Moderna launch new Phase 3 trial for cancer vaccine

Genprex partners with University of Michigan to explore Reqorsa for lung cancer treatment

Virax Biolabs to commercialize ImmuneSelect Portfolio in UK and Ireland via Europa Biosite partnership

United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service

Bicycle Therapeutics unveils promising human imaging data at EANM 2024, targeting next-generation radiopharmaceuticals

BeiGene secures positive CHMP opinions for TEVIMBRA in gastric, gastroesophageal and esophageal cancers